Vertex Pharmaceuticals
company
About
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
- 1001 - 5000
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $5.80M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 1989
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5.80M
Vertex Pharmaceuticals has raised a total of
$5.80M
in funding over 2 rounds. Their latest funding was raised on
Jul 17, 1989 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 17, 1989 | Series Unknown | $5.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Vertex Pharmaceuticals is funded by 1 investors.
Norwest Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Norwest Venture Partners
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
